Showing results (1-10 of 775) with videos related to
Sort By:
Pageof 78
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Weekly Adriamycin vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trial. The Norwegian Breast Cancer GroupS Gundersen, S Kvinnsland, O Klepp, et al.Cancer|May 15, 1991
Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancerS Kaasa, E Lund, E Thorud, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Weekly anthracycline in the treatment of advanced breast cancerS Gundersen, S Kvinnsland, O Klepp, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Chemotherapy with or without high-dose medroxyprogesterone acetate in oestrogen-receptor-negative advanced breast cancer. Norwegian Breast Cancer GroupS Gundersen, S Kvinnsland, O Klepp, et al.European Journal of Cancer & Clinical Oncology|December 1, 1986
Weekly adriamycin versus VAC in advanced breast cancer. A randomized trialS Gundersen, S Kvinnsland, O Klepp, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1988
A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancerS Kaasa, E Thorud, H Høst, et al.Breast Cancer Research and Treatment|November 1, 1990
Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancerS Gundersen, S Kvinnsland, S Lundgren, et al.Scandinavian Journal of Haematology|April 1, 1981
Mantle field irradiation for stages IA and IIA Hodgkin's diseaseA F Abrahamsen, H HøstInternational Journal of Radiation Oncology, Biology, Physics|January 1, 1983
Myelopathy following radiotherapy of bronchial carcinoma with large single fractions: a retrospective studyR Hatlevoll, H Høst, O KaalhusPageof 78